Study: NCT03126695

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor granule
Description: A P2Y12 receptor inhibitor provided as granule for suspension.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor granule
Description: A P2Y12 receptor inhibitor provided as granule for suspension.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor granule
Description: A P2Y12 receptor inhibitor provided as granule for suspension.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ticagrelor granule
Description: A P2Y12 receptor inhibitor provided as granule for suspension.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor pediatric tablets
Description: A P2Y12 receptor inhibitor provided as pediatric tablets to be swallowed whole.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor pediatric tablets
Description: A P2Y12 receptor inhibitor provided as pediatric tablets to be swallowed whole.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor pediatric tablets
Description: A P2Y12 receptor inhibitor provided as pediatric tablets to be swallowed whole.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ticagrelor pediatric tablets
Description: A P2Y12 receptor inhibitor provided as pediatric tablets to be swallowed whole.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor pediatric tablets suspended in water
Description: A P2Y12 receptor inhibitor provided as pediatric tablets suspended in water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor pediatric tablets suspended in water
Description: A P2Y12 receptor inhibitor provided as pediatric tablets suspended in water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor pediatric tablets suspended in water
Description: A P2Y12 receptor inhibitor provided as pediatric tablets suspended in water.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ticagrelor pediatric tablets suspended in water
Description: A P2Y12 receptor inhibitor provided as pediatric tablets suspended in water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor immediate release (IR) tablets (Commercial tablet)
Description: A P2Y12 platelet inhibitor indicated to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (unstable angina, non-ST (S and T waves) elevation MI or ST elevation MI) and in patients with a history of MI

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor immediate release (IR) tablets (Commercial tablet)
Description: A P2Y12 platelet inhibitor indicated to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (unstable angina, non-ST (S and T waves) elevation MI or ST elevation MI) and in patients with a history of MI

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor immediate release (IR) tablets (Commercial tablet)
Description: A P2Y12 platelet inhibitor indicated to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (unstable angina, non-ST (S and T waves) elevation MI or ST elevation MI) and in patients with a history of MI

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ticagrelor immediate release (IR) tablets (Commercial tablet)
Description: A P2Y12 platelet inhibitor indicated to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (unstable angina, non-ST (S and T waves) elevation MI or ST elevation MI) and in patients with a history of MI